DiNuzzo Private Wealth Inc. Takes $73,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

DiNuzzo Private Wealth Inc. bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, Holdings Channel.com reports. The fund bought 138 shares of the healthcare conglomerate’s stock, valued at approximately $73,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. International Assets Investment Management LLC grew its position in UnitedHealth Group by 53,573.1% during the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock worth $1,238,515,000 after purchasing an additional 2,348,107 shares during the last quarter. Jennison Associates LLC increased its position in UnitedHealth Group by 49.3% in the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock valued at $1,904,670,000 after acquiring an additional 1,195,352 shares during the period. Mawer Investment Management Ltd. lifted its position in UnitedHealth Group by 75.0% during the 3rd quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock worth $1,014,002,000 after acquiring an additional 862,024 shares during the period. California Public Employees Retirement System increased its holdings in shares of UnitedHealth Group by 35.9% in the fourth quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock valued at $1,627,311,000 after purchasing an additional 815,822 shares during the period. Finally, Ameriprise Financial Inc. lifted its holdings in shares of UnitedHealth Group by 20.1% during the third quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock worth $1,879,245,000 after purchasing an additional 623,631 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Trading Up 0.9 %

UNH stock traded up $4.33 during midday trading on Wednesday, hitting $488.03. The stock had a trading volume of 1,588,851 shares, compared to its average volume of 4,431,445. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company’s 50-day moving average price is $484.44 and its 200 day moving average price is $513.42. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The firm has a market cap of $449.03 billion, a PE ratio of 29.74, a price-to-earnings-growth ratio of 1.42 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the prior year, the company posted $6.26 EPS. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Analysts Set New Price Targets

Several analysts have recently commented on UNH shares. Bank of America restated a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Oppenheimer reiterated an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Truist Financial reaffirmed a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Finally, Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.